Jay D. Desai, MD

Associate Professor of Clinical Neurology (Practitioner)

Image of Jay D. Desai, MD
Is this your profile? Click to edit

Publications

  • Challenges in the Clinical Recognition of Acute Flaccid Myelitis and its Implications. J Pediatr. 2023 02; 253:55-62.e4.. View in PubMed
  • Factor Analysis of the Einstein Neonatal Neurobehavioral Assessment Scale in Infants with Congenital Heart Disease and Healthy Controls. J Child Neurol. 2022 10; 37(10-11):851-863.. View in PubMed
  • Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis. Epilepsia. 2022 07; 63(7):1714-1723.. View in PubMed
  • Safety of Diazepam Nasal Spray in Children and Adolescents With Epilepsy: Results From a Long-Term Phase 3 Safety Study. Pediatr Neurol. 2022 07; 132:50-55.. View in PubMed
  • Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia. 2021 10; 62(10):2485-2495.. View in PubMed
  • Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study. Epilepsia Open. 2021 09; 6(3):504-512.. View in PubMed
  • Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study. Epilepsy Behav. 2021 07; 120:107983.. View in PubMed
  • Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia. 2021 06; 62(6):1442-1450.. View in PubMed
  • Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study. Epilepsy Behav. 2021 05; 118:107898.. View in PubMed
  • Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology. 2019 04 30; 92(18):e2118-e2126.. View in PubMed
  • Reduced perfusion in Broca’s area in developmental stuttering. Hum Brain Mapp. 2017 04; 38(4):1865-1874.. View in PubMed
  • Proton Chemical Shift Imaging of the Brain in Pediatric and Adult Developmental Stuttering. JAMA Psychiatry. 2017 Jan 01; 74(1):85-94.. View in PubMed